SCHEMBL13355291

SCHEMBL13355291

O=C(NCCc1cccc(-n2ccnc2)n1)Nc1cccc(F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CD38 P28907 2/20 0.51
▸ KMT2A Q03164 1/20 0.49
▸ LMNA P02545 1/20 0.46
▸ FGFR3 P22607 1/20 0.46
▸ KDR P35968 1/20 0.46
▸ NOS1 P29475 4/20 0.46
▸ NOS3 P29474 3/20 0.46
▸ NOS2 P35228 3/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NAMPT P43490 1/20 0.45
▸ CNR1 P21554 1/20 0.44
▸ TAAR1 Q96RJ0 1/20 0.44
▸ CYP3A4 P08684 2/20 0.43
▸ HTR1A P08908 2/20 0.43
▸ ADRA2C P18825 2/20 0.43
▸ HTR2A P28223 2/20 0.43
▸ DRD3 P35462 2/20 0.43
▸ SIGMAR1 Q99720 2/20 0.43
▸ CCR3 P51677 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13355464 0.90 CD38 (0.49) CD38KMT2ALMNAFGFR3KDR
SCHEMBL13355299 0.87 CD38 (0.55) CD38KMT2ALMNAFGFR3KDR
SCHEMBL13355296 0.86 CD38 (0.49) CD38KMT2ALMNAFGFR3KDR
SCHEMBL13355461 0.85 CNR1 (0.46) CD38KMT2AFGFR3KDRALDH1A1
SCHEMBL13355197 0.83 KMT2A (0.50) KMT2ALMNANAMPTCNR1TAAR1
SCHEMBL13355294 0.82 KMT2A (0.47) KMT2ALMNAFGFR3NOS1L3MBTL1
SCHEMBL13355295 0.81 CNR1 (0.47) CD38KMT2AFGFR3KDRALDH1A1
SCHEMBL25136362 0.78 CD38 (0.72) CD38KMT2ACYP3A4
SCHEMBL13355410 0.77 KMT2A (0.55) KMT2ALMNAALDH1A1NAMPTCNR1
SCHEMBL13355302 0.76 NPC1 (0.48) KMT2ALMNANOS2ALDH1A1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010057101-A2 COMPOUNDS USEFUL AS HIV BLOCKERS SCHERING CORPORATION (US) 2010-05-20 — — WO disclosed
Send feedback